PMCB · PharmaCyte Biotech, Inc.
AI read · Neutral
The AI's read
This changes what PharmaCyte holds, but the filing does not show a clear change to its business outlook. The Q/C shares were sized using the calculated value of the warrants, and PharmaCyte paid no cash.